Abstract
Regulation of the profile and magnitude of toll-like receptor (TLR) responses is important for effective host defense against infections while minimizing inflammatory toxicity. The chemokine CXCL4 regulates the TLR8 response to amplify inflammatory gene and inflammasome activation while attenuating the interferon (IFN) response in primary monocytes. In this study, we describe an unexpected role for the kinase RIPK3 in suppressing the CXCL4 + TLR8-induced IFN response and providing signal 2 to activate the NLRP3 inflammasome and interleukin (IL)-1 production in primary human monocytes. RIPK3 also amplifies induction of inflammatory genes such as TNF, IL6, and IL1B while suppressing IL12B. Mechanistically, RIPK3 inhibits STAT1 activation and activates PI3K-Akt-dependent and XBP1- and NRF2-mediated stress responses to regulate downstream genes in a dichotomous manner. These findings identify new functions for RIPK3 in modulating TLR responses and provide potential mechanisms by which RIPK3 plays roles in inflammatory diseases and suggest targeting RIPK3 and XBP1- and NRF2-mediated stress responses as therapeutic strategies to suppress inflammation while preserving the IFN response for host defense.
Original language | English (US) |
---|---|
Pages (from-to) | 615-629 |
Number of pages | 15 |
Journal | Journal of Leukocyte Biology |
Volume | 114 |
Issue number | 6 |
DOIs | |
State | Published - Nov 24 2023 |
Externally published | Yes |
Keywords
- CXCL4
- gene regulation
- inflammation
- NLRP3 inflammasome
- RIPK3
- TLR8
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Cell Biology